A detailed history of Profund Advisors LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Profund Advisors LLC holds 43,182 shares of OCUL stock, worth $374,819. This represents 0.01% of its overall portfolio holdings.

Number of Shares
43,182
Previous 11,868 263.85%
Holding current value
$374,819
Previous $107,000 175.7%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$4.2 - $8.69 $131,518 - $272,118
31,314 Added 263.85%
43,182 $295,000
Q1 2024

May 08, 2024

BUY
$3.85 - $10.93 $45,691 - $129,717
11,868 New
11,868 $107,000
Q3 2023

Nov 13, 2023

BUY
$3.14 - $5.04 $31,710 - $50,898
10,099 Added 94.14%
20,827 $65,000
Q2 2023

Aug 10, 2023

BUY
$4.6 - $7.64 $49,348 - $81,961
10,728 New
10,728 $55,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $668M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.